Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -316 | -23 | -226 | -1,070 | -1,219 |
| Depreciation Amortization | N/A | N/A | 24 | 33 | 34 |
| Accounts receivable | N/A | 1 | -1 | N/A | N/A |
| Other Working Capital | 315 | 18 | 165 | 143 | 510 |
| Other Operating Activity | 0 | -1 | 1 | -21 | -918 |
| Operating Cash Flow | $-1 | $-6 | $-38 | $-915 | $-1,593 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | -65 | N/A | -19 | -39 |
| Other Investing Activity | 0 | -65 | 0 | -20 | -39 |
| Investing Cash Flow | $N/A | $-65 | $N/A | $-20 | $-39 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 7 | 25 | 221 | 56 |
| Common Stock Issued | 949 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 47 | 64 | 0 | 655 | 1,645 |
| Financing Cash Flow | $996 | $71 | $25 | $876 | $1,701 |
| Beginning Cash Position | N/A | 1 | 13 | 72 | 3 |
| End Cash Position | 995 | 2 | 1 | 13 | 72 |
| Net Cash Flow | $995 | $1 | $-13 | $-58 | $69 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1 | -6 | -38 | -915 | -1,593 |
| Free Cash Flow | -1 | -6 | -38 | -915 | -1,593 |